# Curaleaf Holdings, Inc.: Form 40-F/A for the period ended Dec 31, 2022

- Company: [Curaleaf Holdings, Inc.](/companies/curlf.md) (CIK 1756770)
- Form: 40-F/A
- Filed: 2023-05-03
- Accepted by EDGAR: May 3, 2023, 17:29 ET
- Period: 2022-12-31
- Accession: 0001558370-23-007893
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1756770/000155837023007893/curlf-20221231x40fa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1756770/000155837023007893/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2022-01-01 to 2022-12-31 | $1.34bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2022-01-01 to 2022-12-31 | $757.3m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2022-01-01 to 2022-12-31 | $579.0m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months, 2022-01-01 to 2022-12-31 | $447.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2022-01-01 to 2022-12-31 | −$12.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months, 2022-01-01 to 2022-12-31 | $150.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2022-01-01 to 2022-12-31 | −$370.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2022-01-01 to 2022-12-31 | −$0.52 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2022-01-01 to 2022-12-31 | −$0.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2022-01-01 to 2022-12-31 | 711,159,444 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2022-01-01 to 2022-12-31 | $46.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2022-01-01 to 2022-12-31 | $138.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-12-31 | $163.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-12-31 | $605.3m | us-gaap:AssetsCurrent |
| Total assets | at 2022-12-31 | $3.40bn | us-gaap:Assets |
| Current liabilities | at 2022-12-31 | $491.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-12-31 | $2.00bn | us-gaap:Liabilities |
| Long-term debt | at 2022-12-31 | $570.9m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-12-31 | $52.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-12-31 | $1.28bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2022-12-31 | 623,520,125 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1756770/000155837023007893/curlf-20221231x40fa.htm

Filed May 3, 2023.
Source: SEC EDGAR, the filing index for accession 0001558370-23-007893. Last ingested by Listed: Nov 5, 2026, 13:45 ET. No prices; not investment advice.